These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19665766)

  • 1. Genetics and pharmacogenetics of the leukotriene pathway.
    Tantisira KG; Drazen JM
    J Allergy Clin Immunol; 2009 Sep; 124(3):422-7. PubMed ID: 19665766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene pathway genetics and pharmacogenetics in allergy.
    Duroudier NP; Tulah AS; Sayers I
    Allergy; 2009 Jun; 64(6):823-39. PubMed ID: 19416143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
    Theron AJ; Steel HC; Tintinger GR; Gravett CM; Anderson R; Feldman C
    J Immunol Res; 2014; 2014():608930. PubMed ID: 24971371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast.
    Klotsman M; York TP; Pillai SG; Vargas-Irwin C; Sharma SS; van den Oord EJ; Anderson WH
    Pharmacogenet Genomics; 2007 Mar; 17(3):189-96. PubMed ID: 17460547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of asthma with drugs modifying the leukotriene pathway.
    Drazen JM; Israel E; O'Byrne PM
    N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
    Lima JJ
    Mol Diagn Ther; 2007; 11(2):97-104. PubMed ID: 17397245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of asthma.
    Palmer LJ; Silverman ES; Weiss ST; Drazen JM
    Am J Respir Crit Care Med; 2002 Apr; 165(7):861-6. PubMed ID: 11934710
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukotrienes, antileukotrienes and asthma.
    Montuschi P
    Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase.
    Choi JH; Park HS; Oh HB; Lee JH; Suh YJ; Park CS; Shin HD
    Hum Genet; 2004 Mar; 114(4):337-44. PubMed ID: 14749922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of treatment with leukotriene modifiers.
    Wechsler ME; Israel E
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):395-401. PubMed ID: 12582322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies.
    Thompson MD; Capra V; Clunes MT; Rovati GE; Stankova J; Maj MC; Duffy DL
    Front Pharmacol; 2016; 7():299. PubMed ID: 27990118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-leukotrienes for asthma.
    Calhoun WJ
    Curr Opin Pharmacol; 2001 Jun; 1(3):230-4. PubMed ID: 11712744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of asthma--focus on leukotrienes.
    Crowther SD; Rees PJ
    Expert Opin Pharmacother; 2000 Jul; 1(5):1021-40. PubMed ID: 11249493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
    Tantisira KG; Lima J; Sylvia J; Klanderman B; Weiss ST
    Pharmacogenet Genomics; 2009 Mar; 19(3):244-7. PubMed ID: 19214143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma.
    Kotani H; Kishi R; Mouri A; Sashio T; Shindo J; Shiraki A; Hiramatsu T; Iwata S; Taniguchi H; Nishiyama O; Iwata M; Suzuki R; Gonda H; Niwa T; Kondo M; Hasegawa Y; Kume H; Noda Y
    J Clin Pharm Ther; 2012 Feb; 37(1):112-6. PubMed ID: 21385196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the understanding of leukotrienes in asthma.
    Coffey M; Peters-Golden M
    Curr Opin Allergy Clin Immunol; 2003 Feb; 3(1):57-63. PubMed ID: 12582316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
    Steinke JW; Culp JA
    Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the role of leukotrienes in asthma.
    Hallstrand TS; Henderson WR
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):60-6. PubMed ID: 19915456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 927T> C CYSLTRI and -444A > C LTC4S polymorphisms in patients with asthma.
    Sanz C; Isidro-García M; Dávila I; Moreno E; Laffond E; Lorente F
    J Investig Allergol Clin Immunol; 2006; 16(6):331-7. PubMed ID: 17153879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.